Jill Brooks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jill Brooks has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
A. Mengistu
Sodo, Ethiopia
1 shared publication- E. Gardiner
University of Hull, Hull, U.K.
1 shared publication - Fiona Cowdell
School of Nursing and Midwifery Birmingham City University Birmingham UK
1 shared publication - Jonathan Cooke
Imperial College London, London, UK; University of Manchester, Manchester, UK
1 shared publication - Matthew Dryden
Global Operations, UK Health Security Agency , Porton Down
1 shared publication P.J. Matts
Procter & Gamble, Greater London Innovation Centre, Egham, Surrey, U.K.
1 shared publication
Latest Publications
- 1 November 2017
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 177 (5) , 1422-1431
A randomized controlled trial to evaluate the effect of a new skincare regimen on skin barrier function in those with podoconiosis in Ethiopia
Podoconiosis affects an estimated 3 million people in Ethiopia with a further 19 million at risk. Volcanic soil and pathogens enter skin breaches in the feet causing inflammation, lymphoedema and hyperkeratosis. There is no robust evidence on optimal podoconiosis skin care regimens to improve SBF. To evaluate the effectiveness of a new, low-cost, evidence-based intervention to improve SBF in the lower limbs of those with podoconiosis. A randomized control trial (RCT) was conducted over 3 months in two podoconiosis clinics (n=193). The intervention comprised 2% glycerine (v/v) added to a reduced amount of soaking water. The control group received the current skin care regimen. Primary outcome measures were trans-epidermal water loss (TEWL) and stratum corneum hydration (SCH) at four specific sites on the lower limbs. Improvement in SBF was observed in both groups across all measurement sites and time points, although this was significantly greater in the experimental group. TEWL reduced in both groups at all sites. For example, on top of the foot the estimated group difference in TEWL at the fourth visit was 1.751 (SE=0.0390) in favour of the experimental group (t=3.154, df=189.580, p=0.002, 95% CI (0.0656 to 2.846)), indicating a greater reduction in the experimental group. Similarly, at the same site the estimated group difference in SCH at the fourth visit was -2.041(CI=0.572) in favour of the experimental group (t=-3.565, df=186.739, p=<0.001), 95% CI (-3.168 to -0.911)), indicating a greater increase in the experimental group. There were also significantly greater reductions in odour, number of wounds and largest foot circumference in the experimental compared to the control group. The addition of 2% glycerine (v/v) to a reduced volume (83% reduction) of soaking water significantly improved SBF (Registered trial NCT02839772)
- 1 November 2017
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 177 (5) , 1422-1431
A randomized controlled trial to evaluate the effect of a new skincare regimen on skin barrier function in those with podoconiosis in Ethiopia
Podoconiosis affects an estimated 3 million people in Ethiopia with a further 19 million at risk. Volcanic soil and pathogens enter skin breaches in the feet causing inflammation, lymphoedema and hyperkeratosis. There is no robust evidence on optimal podoconiosis skin care regimens to improve SBF. To evaluate the effectiveness of a new, low-cost, evidence-based intervention to improve SBF in the lower limbs of those with podoconiosis. A randomized control trial (RCT) was conducted over 3 months in two podoconiosis clinics (n=193). The intervention comprised 2% glycerine (v/v) added to a reduced amount of soaking water. The control group received the current skin care regimen. Primary outcome measures were trans-epidermal water loss (TEWL) and stratum corneum hydration (SCH) at four specific sites on the lower limbs. Improvement in SBF was observed in both groups across all measurement sites and time points, although this was significantly greater in the experimental group. TEWL reduced in both groups at all sites. For example, on top of the foot the estimated group difference in TEWL at the fourth visit was 1.751 (SE=0.0390) in favour of the experimental group (t=3.154, df=189.580, p=0.002, 95% CI (0.0656 to 2.846)), indicating a greater reduction in the experimental group. Similarly, at the same site the estimated group difference in SCH at the fourth visit was -2.041(CI=0.572) in favour of the experimental group (t=-3.565, df=186.739, p=<0.001), 95% CI (-3.168 to -0.911)), indicating a greater increase in the experimental group. There were also significantly greater reductions in odour, number of wounds and largest foot circumference in the experimental compared to the control group. The addition of 2% glycerine (v/v) to a reduced volume (83% reduction) of soaking water significantly improved SBF (Registered trial NCT02839772)
- 1 March 2017
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 8, 194-198
Hot topics in reactive oxygen therapy: Antimicrobial and immunological mechanisms, safety and clinical applications
- 1 March 2017
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 8, 194-198
Hot topics in reactive oxygen therapy: Antimicrobial and immunological mechanisms, safety and clinical applications